Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The FDA approved Mylan's biosimilar cancer drug Ogivri Dec. 1.
Here are seven articles Becker's Hospital Review published in the last week, highlighting an amino acids shortage exacerbated by manufacturing issues in Puerto Rico, and CVS' launch of free same-day delivery services in New York City, among other topics.
FDA Commissioner Scott Gottlieb, MD, released three policy guidelines Dec. 7 outlining the agency's approach to digital health oversight.
Spending on prescription drugs in the U.S. slowed in 2016, following a two-year surge, according to an analysis from CMS.
Hospital pharmacists are taking on a greater role in organizations' strategic initiatives in recent years, with pharmacists leading medication reconciliation and patient discharge programs. However, deploying pharmacists to drive these clinical initiatives creates a shortage in the workforce needed to…
Pfizer will release a generic version of Viagra to U.S. consumers once its patent for the drug expires Dec. 11, MLive reports.
The FDA is urging Primus Pharmaceuticals, a Scottsdale, Ariz.-based drugmaker, to voluntarily recall its osteoarthritis product Limbrel due to increased reports of adverse events following prolonged use of the product.
Amazon reportedly rescinded an application for a wholesaler pharmaceutical license in Maine, according to analyst insights cited by CNBC.
Amazon earned a patent for a drone designed to self-destruct during emergencies, reports NBC News.
Novo Nordisk on Tuesday earned FDA approval for its diabetes drug Ozempic.